Pfizer seeks emergency use of COVID-19 vaccine in India
Pfizer India has become the first pharmaceutical firm to seek an emergency use authorization for its COVID-19 vaccine in India, which has the second highest number of coronavirus infections.
“Pfizer India has submitted an application on December 4 to the DCGI seeking emergency use authorization (EUA) for its COVID-19 vaccine in India,” Indian media reported on Sunday, referring to the Drugs Controller General of India (DCGI).
“Pfizer India has sought permission for emergency usage authorization of its COVID-19 from DGCI to import and market,” an official was quoted as saying.
Pfizer India is a subsidiary of the parent company Pfizer Inc., an American multinational pharmaceutical corporation based in New York.
The United Kingdom on Wednesday became the first country to approve the Pfizer/BioNTech vaccine against COVID-19, with the UK regulator Medicines and Healthcare products Regulatory Agency (MHRA) granting a temporary authorization for its emergency use.
India has reported more 9.57 million COVID–19 cases, behind only the United States, with nearly 140,000 deaths.
Kashmir votes in first regional poll after special status scrapped
Bangladesh to seek extradition of ousted leader Hasina from India
Indian doctors agree to end strike over brutal rape, murder of female colleague
Leader pardons, commutes sentences of about 3,000 convicts
Dead bodies desecrated as Israeli forces step up carnage in West Bank
Probe finds devices ‘booby-trapped’ before entering Lebanon
Sept. 19: ‘Axis of Resistance’ operations against Israeli occupation
‘Skin diseases threaten lives of Palestinians held in Israel's Ofer prison’
'Heinous crime': Israeli forces throw Palestinians’ bodies off building in Jenin
Yemen prepared for long war with Israel, says defense minister
VIDEO | Historic UN vote demands Israel quit Occupied Territories in one year
PressTV NEWSLETTER
now
This makes it easy to access the Press TV website
